Activin as an anti-inflammatory cytokine produced by microglia

Journal of Neuroimmunology

Volumn 192, Issue 1-2, 2007, Pages 31-39

  Sugama, Shuei ^a,b   Takenouchi, Takato ^c   Kitani, Hiroshi ^c   Fujita, Masayo ^b   Hashimoto, Makoto ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

Activin; Anti inflammatory; Lipopolysaccharide; Microglia; Proinflammatory

Indexed keywords

ACTIVIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; INFLAMMATION; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ACTIVINS; ANIMALS; ANTIGENS, CD11B; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; LATERAL VENTRICLES; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II;

EID: 36749083392     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.08.016     Document Type: Article

References (56)

1. Banati R.B., Daniel S.E., and Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13 (1998) 221-227
2. Block M.L., and Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76 (2005) 77-98
3. Brosh N., Sternberg D., Honigwachs-Shaanani J., Lee B.-C., Shav-Tal Y., Tzehoval E., et al. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11: identification as a stroma derived activin A. J. Biol. Chem. 270 (1995) 29594-29600
4. Chen Y.G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., and Massague J. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12 14 (1998) 2144-2152
5. Cho B.P., Song D.Y., Sugama S., Shin D.H., Shimizu Y., Kim S.S., Kim Y.S., and Joh T.H. Pathological dynamics of activated microglia following medial forebrain bundle transaction. Glia 53 (2006) 92-102
6. Czlonkowska A., Kohutnicka M., Kurkowska-Jastrzebska I., and Czlonkowski A. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration 5 2 (1996) 137-143
7. Delgado M., and Ganea D. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation. FASEB J. 17 8 (2003) 944-946
8. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., and Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7 1 (1993) 75-83
9. Dignass A.U., Jung S., Harder-d'Heureuse J., and Wiedenmann B. Functional relevance of activin A in the intestinal epithelium. Scand. J. Gastroenterol. 37 (2005) 936-943
10. Ebert S., Zeretzke M., Nau R., and Michel U. Microglial cells and peritoneal macrophages release activin A upon stimulation with Toll-like receptor agonists. Neurosci. Lett. 413 3 (2006) 241-244
11. Fujita M., Sugama S., Nakai M., Takenouchi T., Wei J., Urano T., Inoue S., and Hashimoto M. Alpha-synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity. J. Biol. Chem. 282 8 (2007) 5736-5748
12. Gu Y., et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275 (1997) 206-209
13. Ghayur T., et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386 (1997) 619-623
14. Hedger M.P., Philips D.J., and de Kretser D.M. Divergent cell-specific effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin 1 beta or interleukin 6 in vitro. Cytokine 12 (2000) 595-602
15. Hedtjarn M., Leverin A.L., Eriksson K., Blomgren K., Mallard C., and Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22 14 (2002) 5910-5919
16. Hirsch E.C., Breidert T., Rousselet E., Hunot S., Hartmann A., and Michel P.P. The role of glial reaction and inflammation in Parkinson's disease. Ann. N. Y. Acad. Sci. 991 (2003) 214-228
17. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B., and Hirsch E.C. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19 9 (1999) 3440-3447
18. Hughes P.E., Alexi T., Williams C.E., Clark R.G., and Gluckman P.D. Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 92 1 (1999) 197-209
19. Iwahori Y., Saito H., Torii K., and Nishiyama N. Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res. 760 1-2 (1997) 52-58
20. Iwamaru Y., Takenouchi T., Ogihara K., Hoshino M., Takata M., Imamura M., Tagawa Y., Hayashi-Kato H., Ushiki-Kaku Y., Shimizu Y., Okada H., Shinagawa M., Kitani H., and Yokoyama T. Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J. Virol. 81 3 (2007) 1524-1527
21. Jander S., Schroeter M., and Stoll G. Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J. Cereb. Blood Flow Metab. 22 1 (2002) 62-70
22. Jones K.L., Brauman J.N., Groome N.P., de Krestser D.M., and Phillips D.J. Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology 14 (2000) 1905-1908
23. Jones K.L., de Kretser D.M., Clarke I.J., Scheerlinck J.P., and Phillips D.J. Characterization of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. J. Endocrinol. 182 (2004) 69-80
24. Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., and Czlonkowska A. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 56 (1999) 50-61
25. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
26. Krieglstem K., Suter-Crazzolara C., Fischer W.H., and Unsicker K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14 4 (1995) 736-742
27. Li H., Newcombe J., Groome N.P., and Cuzner M.L. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 19 3 (1993) 214-223
28. Li Q., Karam S.M., Coerver K.A., Matzuk M.M., and Gordon J.I. Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages. Mol. Endocrinol. 12 (1998) 181-192
29. Mathews L.S., and Vale W.W. Molecular and functional characterization of activin receptors. Receptor 3 3 (1993) 173-181
30. Maeshima A., Nojima Y., and Kojima I. Activin A: an autocrine regulator of cell growth and differentiation in renal proximal tubular cells. Kidney Int. 62 (2002) 446-454
31. McGeer P.L., Itagaki S., Boyes B.E., and McGeer G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
32. Michel U., Gerber J.E., O'Connor A., Bunkowski S., Bruck W., Nau R., et al. Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia. J. Neurochem. 86 (2003) 238-245
33. Nakamichi K., Saiki M., Kitani H., Kuboyama Y., Morimoto K., Takayama-Ito M., and Kurane I. Roles of NF-kappaB and MAPK signaling pathways in morphological and cytoskeletal responses of microglia to double-stranded RNA. Neurosci. Lett. 414 3 (2007) 222-227
34. Nakamichi K., Saiki M., Kitani H., Kuboyama Y., Morimoto K., Takayama-Ito M., and Kurane I. Suppressive effect of simvastatin on interferon-beta-induced expression of CC chemokine ligand 5 in microglia. Neurosci. Lett. 407 3 (2006) 205-210
35. Nusing R.M., and Barsig J. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br. J. Pharmacol. 127 (1999) 919-926
36. Ogawa K., Funaba M., Mathews L.S., and Mizutani T. Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J. Immunol. 165 (2000) 2997-3003
37. Ohguchi M., Yamato K., Ishihara Y., Koide M., Ueda N., Okahashi N., et al. Activin A regulates the production of mature interleukin-1b and interleukin-1 receptor antagonist in human monocytic cells. J. Interferon Cytokine Res. 18 (1998) 491-498
38. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., and Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55 5 (2007) 453-462
39. Russell C.E., Hedger M.P., Brauman J.N., de Kretser D.M., and Phillps D.J. Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol. Cell. Endocrinol. 148 (1999) 129-136
40. + channel expression in microglia via distinct signalling pathways. Eur. J. Neurosci. 14 3 (2001) 463-473
41. Smith C., Yndestad A., Halvorsen B., Ueland T., Wachre T., Otterdal K., et al. Potential anti-inflammatory role of activin A in acute coronary syndromes. J. Am. Coll. Cardiol. 44 (2004) 369-375
42. Schubert D., Kimura H., LaCorbiere M., Vaughan J., Karr D., and Fischer W.H. Activin is a nerve cell survival molecule. Nature 344 (1990) 868-870
43. Sugama S., Cho B.P., DeGiorgio L.A., Shimizu Y., Kim S.S., Kim Y.S., Shin D.H., Volpe B.T., Reis D.J., Cho S., and Joh T.H. Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat. Neuroscience 116 (2003) 925-933
44. Sugama S., Yang L., Cho B.P., DeGiorgio L.A., Lorenzl S., Albers D.S., Beal M.F., Volpe B.T., and Joh T.H. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6. Brain Res. 964 (2003) 288-294
45. Sugama S., Wirz S.A., Barr A.M., Conti B., Bartfai T., and Shibasaki T. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Neuroscience 128 (2004) 451-458
46. Sugama S., Fujita M., Hashimoto M., Conti B., 2007. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience 146 (3), 1388-1399.
47. Sulyok S., Wankell M., Alzheimer C., and Werner S. Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Molecular and Cellular Endocrinology 225 (2004) 127-132
48. 2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line. Biochim. Biophys. Acta 1726 2 (2005) 177-186
49. 2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J. Neurochem 102 (5), 1518-1532.
50. Waragai M., Wei J., Fujita M., Nakai M., Ho G.J., Masliah E., Akatsu H., Yamada T., and Hashimoto M. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem. Biophys. Res. Commun. 343 (2006) 967-972
51. Werner S., and Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine & Growth Factor Rev. 17 (2006) 157-171
52. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., and Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22 5 (2002) 1763-1771
53. Wu D.D., Lai M., Hughes P.E., Sirimanne E., Gluckman P.D., and Williams C.E. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res. 835 2 (1999) 369-378
54. Yasuda H., Mine T., Shibata H., Eto Y., Hasegawa Y., Takeuchi T., et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J. Clin. Invest. 92 (1993) 1491-1496
55. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., and Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53 3 (2007) 337-351
56. Zhang X.J., Li Y., Tai G.X., Xu G.Y., Zhang P.Y., Yang Y., Lao F.X., and Liu Z.H. Effects of activin A on the activities of the mouse peritoneal macrophages. Cell. Mol. Immunol. 2 1 (2005) 63-67